IMS New Era of Switch
Overview
examines what new launches mean for the pharmaceutical industry - from both a prescription-bound and over-the-counter perspective.
This new report from IMS Consumer Health examines what these new launches mean for the pharmaceutical industry - from both a prescription-bound and over-the- counter perspective.


The report will discuss developments in Europe, North America and Pacific Rim with reference to the following:

- Company Structure
- Marketing Strategies
- Advertising
- Channels of Communication
- Stakeholder Opinions of Current Switching
- Impact of Recent Switches on Other Markets

Regulatory Environment - Legislative Framework for Switching
- Reimbursement & Switching

Marketing Issues - Company Structure
- Marketing Strategies
- Advertising
- Channels of Communication

Recent Switches - Stakeholder Opinions of Current Switching
- Impact of Recent Switches on Other Markets

Potential Switches in the Future - Potential Molecules / Indications for Future OTC Switching
- Current Rx Market Size of Selected Indications & Potential OTC Share
- Leading Corporations & Brands

Country Coverage Individual country profiles will be provided for the
following countries:
Western Europe: France, Germany, Italy, Spain, UK
North America: Canada, USA Pacific Rim: Australia, NZ

Research Method Qualitative
Face-to-face / telephone interviews will be conducted
with leading experts / stakeholders in above countries.
- Pharmacists / Pharmacists’ Associations
- Doctors / Doctors’ Associations
- Consumer / Patient Associations
- Health Officials
- Industry Associations

Contact Us
For more information about this offering, please contact us or call Rick Hindle at +44 (0)20 7393 5000